PURE Bioscience, Inc. (PURE)
OTCMKTS: PURE · Delayed Price · USD
0.0680
+0.0060 (9.68%)
Jul 2, 2024, 9:53 AM EDT - Market closed

PURE Bioscience Statistics

Total Valuation

PURE has a market cap or net worth of $7.61 million. The enterprise value is $9.49 million.

Market Cap 7.61M
Enterprise Value 9.49M

Important Dates

The last earnings date was Wednesday, June 14, 2023, after market close.

Earnings Date Jun 14, 2023
Ex-Dividend Date n/a

Share Statistics

PURE has 111.86 million shares outstanding. The number of shares has increased by 0.45% in one year.

Shares Outstanding 111.86M
Shares Change (YoY) +0.45%
Shares Change (QoQ) n/a
Owned by Insiders (%) 40.45%
Owned by Institutions (%) n/a
Float 66.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.64
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.54
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.30

Current Ratio 1.30
Quick Ratio 1.13
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -31.08

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -394.13%
Return on Capital (ROIC) -1,384.25%
Revenue Per Employee $190,091
Profits Per Employee -$329,636
Employee Count 11
Asset Turnover 1.43
Inventory Turnover 8.01

Taxes

In the past 12 months, PURE has paid $8,000 in taxes.

Income Tax 8,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -15.00% in the last 52 weeks. The beta is 0.11, so PURE's price volatility has been lower than the market average.

Beta (5Y) 0.11
52-Week Price Change -15.00%
50-Day Moving Average 0.08
200-Day Moving Average 0.10
Relative Strength Index (RSI) 45.79
Average Volume (20 Days) 29,586

Short Selling Information

The latest short interest is 222,969, so 0.20% of the outstanding shares have been sold short.

Short Interest 222,969
Short Previous Month 254,799
Short % of Shares Out 0.20%
Short % of Float 0.33%
Short Ratio (days to cover) 2.56

Income Statement

In the last 12 months, PURE had revenue of $2.09 million and -$3.63 million in losses. Loss per share was -$0.03.

Revenue 2.09M
Gross Profit 1.20M
Operating Income -3.52M
Pretax Income -3.63M
Net Income -3.63M
EBITDA -3.08M
EBIT -3.20M
Loss Per Share -$0.03
Full Income Statement

Balance Sheet

The company has $517,000 in cash and $2.40 million in debt, giving a net cash position of -$1.88 million or -$0.02 per share.

Cash & Cash Equivalents 517,000
Total Debt 2.40M
Net Cash -1.88M
Net Cash Per Share -$0.02
Equity (Book Value) -2.15M
Book Value Per Share -0.02
Working Capital 203,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.68 million and capital expenditures $43,000, giving a free cash flow of -$2.64 million.

Operating Cash Flow -2.68M
Capital Expenditures 43,000
Free Cash Flow -2.64M
FCF Per Share -$0.02
Full Cash Flow Statement

Margins

Gross margin is 57.29%, with operating and profit margins of -168.15% and -173.41%.

Gross Margin 57.29%
Operating Margin -168.15%
Pretax Margin -173.41%
Profit Margin -173.41%
EBITDA Margin -147.11%
EBIT Margin -153.08%
FCF Margin -126.21%

Dividends & Yields

PURE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.45%
Shareholder Yield -0.45%
Earnings Yield -47.67%
FCF Yield -34.70%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on August 15, 2012. It was a reverse split with a ratio of 1:8.

Last Split Date Aug 15, 2012
Split Type Reverse
Split Ratio 1:8

Scores

PURE has an Altman Z-Score of -214.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -214.17
Piotroski F-Score 3